WallStSmart
ELVN

Enliven Therapeutics Inc.

NASDAQ: ELVN · HEALTHCARE · BIOTECHNOLOGY

$42.40
-1.35% today

Updated 2026-04-29

Market cap
$2.58B
P/E ratio
P/S ratio
EPS (TTM)
$-1.83
Dividend yield
52W range
$15 – $49
Volume
1.2M

Enliven Therapeutics Inc. (ELVN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+1.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-4.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.6%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-9.5%
2026-03-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-12$-0.48-27.1%$30.70$27.77-9.5%
2025-11-12$-0.32+36.0%$19.64$20.27+3.2%
2025-08-13$-0.49+10.9%$18.89$19.77+4.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.38$-0.48-27.1%
2025-09-30$-0.50$-0.32+36.0%
2025-06-30$-0.55$-0.49+10.9%
2025-03-31$-0.50$-0.57-13.0%
2024-12-31$-0.52$-0.46+11.1%$316000.00-28.2%
2024-09-30$-0.50$-0.48+4.4%
2024-06-30$-0.55$-0.41+25.5%
2024-03-31$-0.57$-0.54+5.3%
2023-12-31$-0.54$-0.47+13.0%$440000.00
2023-09-30$-0.47$-0.51-8.5%
2023-06-30$-0.36$-0.41-13.9%
2023-03-31$-0.63$-0.80-27.0%

Frequently asked questions

Has Enliven Therapeutics Inc. beaten earnings estimates?
Enliven Therapeutics Inc. has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +1.7% over the last 4 quarters.
How does ELVN stock react to earnings?
ELVN stock has moved an average of -0.6% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.